Neurothera Labs Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	0.86	1.31
Revenue Growth (YoY)	-34.46%	-
Cost of Revenue	0.23	0.8
Gross Profit	0.63	0.51
Selling, General & Admin	1.57	1.6
Research & Development	1.8	1.71
Operating Expenses	3.37	3.31
Operating Income	-2.74	-2.81
Interest Expense	-0.13	-
Interest & Investment Income	0.04	0.02
Other Non Operating Income (Expenses)	-1.41	-
EBT Excluding Unusual Items	-4.23	-2.78
Asset Writedown	-0.12	-1.34
Pretax Income	-4.34	-4.13
Income Tax Expense	0.02	-
Earnings From Continuing Operations	-4.36	-4.13
Minority Interest in Earnings	0.24	1.19
Net Income	-4.12	-2.94
Net Income to Common	-4.12	-2.94
Shares Outstanding (Basic)	67	63
Shares Outstanding (Diluted)	67	63
Shares Change (YoY)	6.54%	-
EPS (Basic)	-0.06	-0.05
EPS (Diluted)	-0.06	-0.05
Gross Margin	73.72%	38.74%
Operating Margin	-319.74%	-214.78%
Profit Margin	-481.66%	-225.27%
EBITDA	-2.54	-2.44
EBITDA Margin	-297.08%	-186.75%
D&A For EBITDA	0.19	0.37
EBIT	-2.74	-2.81
EBIT Margin	-	-214.78%
Advertising Expenses	0.16	0.37